POTIGA Drug Patent Profile
✉ Email this page to a colleague
When do Potiga patents expire, and what generic alternatives are available?
Potiga is a drug marketed by Glaxosmithkline and is included in one NDA.
The generic ingredient in POTIGA is ezogabine. Additional details are available on the ezogabine profile page.
Summary for POTIGA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 102 |
| Clinical Trials: | 3 |
| Patent Applications: | 1,236 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for POTIGA |
| DailyMed Link: | POTIGA at DailyMed |
Recent Clinical Trials for POTIGA
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Baylor College of Medicine | Phase 2 |
| James Murrough | Phase 2 |
| National Institute of Mental Health (NIMH) | Phase 2 |
US Patents and Regulatory Information for POTIGA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | POTIGA | ezogabine | TABLET;ORAL | 022345-001 | Jun 10, 2011 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Glaxosmithkline | POTIGA | ezogabine | TABLET;ORAL | 022345-004 | Jun 10, 2011 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Glaxosmithkline | POTIGA | ezogabine | TABLET;ORAL | 022345-002 | Jun 10, 2011 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
